Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction

Overview of attention for article published in JACC: Basic to Translational Science, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 42 X posts from 39 X users, with an upper bound of 217,649 followers.

RT @JACCJournals: Can protein kinase C inhibition provide an inotropic treatment in heart failure patients? #JACCBTS #openaccess #research…

PKC inhibition might be helpful in heart failure... new work from Molkentin and his colleagues... https://t.co/ZNqcIiIyHo https://t.co/ZNqcIiIyHo

RT @JACCJournals: Can protein kinase C inhibition provide an inotropic treatment in heart failure patients? #JACCBTS #openaccess #research…

RT @JACCJournals: Can protein kinase C inhibition provide an inotropic treatment in heart failure patients? #JACCBTS #openaccess #research…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 38 additional X posts.